PATENT CLAIM ANALYSIS

Application Number: 15957494
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "247100"]

Abstract:
Methods are disclosed herein for treating depression in the subject. A method includes the use of Botulinum toxin to cause paralysis of a facial muscle, such as the depressor anguli oris, procerus, frontalis, orbicularis oculi, or corrugator supercilii muscle to treat depression in the subject.

Claim (Index 6):
The method of  claim 5 , wherein the botulinum toxin in the composition is botulinum toxin A.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.36842
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15388840', '13789216', '12813373', '10773785', '14746299']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8289582244952247
- 35 USC 102 Novelty (BERT): 0.6914436966950073
- Combined Prediction Score: 0.8152067717152031
- Mean Citation Score: 657.5374680000001
- Max Citation Score: 700.1339999999999
- Similarity Product: 697.131353937149

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test